Difference between revisions of "Classical Hodgkin lymphoma - historical"
m (Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm") |
m (Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II") |
||
Line 105: | Line 105: | ||
|- | |- | ||
|[http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19801201)46:11%3C2349::AID-CNCR2820461105%3E3.0.CO;2-V/abstract Rodgers et al. 1980] | |[http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19801201)46:11%3C2349::AID-CNCR2820461105%3E3.0.CO;2-V/abstract Rodgers et al. 1980] | ||
− | | | + | |style="background-color:#EEEE00"|Phase II |
− | style="background | ||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|} | |} |
Revision as of 05:58, 4 December 2016
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.
The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s) of a randomized study, unless said regimens continue to be recommended by trustworthy sources such as the NCCN Guidelines. See the Hodgkin lymphoma page for current regimens.
30 regimens on this page
37 variants on this page
|
Untreated
CVPP
back to top |
CVPP: CCNU (Lomustine), Vinblastine, Procarbazine, Prednisone
Regimen
Study | Evidence | Comparator |
Cooper et al. 1980 | Phase III | MOPP MVPP |
References
- Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease. Cancer. 1980 Aug 15;46(4):654-62. link to original article PubMed
MVPP
back to top |
MVPP: Mechlorethamine, Vinblastine, Procarbazine, Prednisone
Regimen
Study | Evidence | Comparator |
Cooper et al. 1980 | Phase III | CVPP MOPP |
References
- Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease. Cancer. 1980 Aug 15;46(4):654-62. link to original article PubMed
SCAB
back to top |
SCAB: Streptozocin, CCNU (Lomustine), Adriamycin (Doxorubicin), Bleomycin
Regimen
Study | Evidence |
Diggs et al. 1981 | Non-randomized |
References
- Diggs CH, Wiernik PH, Sutherland JC. Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP. Cancer. 1981 Jan 15;47(2):224-8. link to original article PubMed
- Update: Wiernik PH, Schiffer CA. Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB). J Cancer Res Clin Oncol. 1988;114(1):105-7. PubMed
Relapsed/Refractory
ABDIC
back to top |
ABDIC: Adriamycin (Doxorubicin), Bleomycin, DIC (Dacarbazine), CCNU (Lomustine), Prednisone
Regimen
Study | Evidence |
Rodgers et al. 1980 | Phase II |
References
- Rodgers RW, Gamble JF, Loh KK, Shullenberger CC. Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. Cancer. 1980 Dec 1;46(11):2349-55. link to original article PubMed
- Update: Tannir N, Hagemeister F, Velasquez W, Cabanillas F. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease. J Clin Oncol. 1983 Jul;1(7):432-9. link to original article PubMed
ABVD
back to top |
ABVD: Adriamycin (Doxorubicin), Bleomycin, Vinblastine, Dacarbazine
Regimen
Study | Evidence |
Krikorian et al. 1978 | Phase II |
Santoro et al. 1979 | Phase II |
Harker et al. 1984 | Non-randomized |
This is for historical interest only; ABVD is no longer used in the salvage setting.
References
- Krikorian JG, Portlock CS, Rosenberg SA. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy. Cancer. 1978 Jun;41(6):2107-11. link to original article PubMed
- Santoro A, Bonadonna G. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Cancer Chemother Pharmacol. 1979;2(2):101-5. PubMed
- Santoro A, Bonfante V, Bonadonna G. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med. 1982 Feb;96(2):139-43. link to original article PubMed
- Harker WG, Kushlan P, Rosenberg SA. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. Ann Intern Med. 1984 Oct;101(4):440-6. link to original article PubMed
B-CAVe
back to top |
B-CAVe: Bleomycin, CCNU (Lomustine), Adriamycin (Doxorubicin), Vinblastine
Regimen
Study | Evidence | ||
Porzig et al. 1978 | Non-randomized | ||
Harker et al. 1984 | Non-randomized |
References
- Porzig KJ, Portlock CS, Robertson A, Rosenberg SA. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure. Cancer. 1978 May;41(5):1670-5. link to original article PubMed
- Harker WG, Kushlan P, Rosenberg SA. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. Ann Intern Med. 1984 Oct;101(4):440-6. link to original article PubMed
BVCPP
back to top |
BVCPP: BCNU (Carmustine), Vinblastine, Cyclophosphamide, Procarbazine, Prednisone
Regimen
Study | Evidence |
Durant et al. 1978 | Non-randomized |
Patients who achieved CR were randomized to no additional therapy, 6 monthly cycles of MOPP or 6 additional monthly cycles of BVCPP.
References
- Durant JR, Gams RA, Velez-Garcia E, Bartolucci A, Wirtschafter D, Dorfman R. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease. Cancer. 1978 Nov;42(5):2101-10. link to original article PubMed
CEP
back to top |
CEP: CCNU (Lomustine), Etoposide, Prednimustine
Regimen
Study | Evidence |
Santoro et al. 1986 | Non-randomized |
References
- Santoro A, Viviani S, Valagussa P, Bonfante V, Bonadonna G. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. Semin Oncol. 1986 Mar;13(1 Suppl 1):23-6. PubMed
SCAB
back to top |
SCAB: Streptozocin, CCNU (Lomustine), Adriamycin (Doxorubicin), Bleomycin
Regimen
Study | Evidence |
Levi et al. 1977 | Non-randomized, <20 patients |
References
- Levi JA, Wiernik PH, Diggs CH. Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin. Med Pediatr Oncol. 1977;3(1):33-40. PubMed